Clinical trial
Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid…
NCT00056238 · Bellus Health Inc. - a GSK company, Industry · Completed
Key facts
| NCT number | NCT00056238 |
|---|---|
| Title | Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy |
| Official title | A Phase II Pilot Study of the Safety, Tolerability and Pharmacokinetics of Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy |
| Lead sponsor | Bellus Health Inc. - a GSK company, Industry |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke, Neurologic Diseases, General |
| Intervention type | Drug |
| Interventions | NC-758 (Anti amyloidotic [Aß] agent) |
| Enrollment | 30 |
| Start date | Feb 1, 2003 |
| First posted | Mar 10, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: